Net Income

Bitcoin miner Abits Group raises needed cash in a dilutive offering, sending its stock plunging and shining a spotlight on its controversial dealmaker.

With strong growth in key sectors but weakness in others, Plexus management faces a pivotal moment at the upcoming Raymond James investor conference.

How a unique Japanese hospitality philosophy helped Japan House London beat 1,600 rivals to be crowned the best visitor experience in the UK's cultural sector.

Toymaker JAKKS Pacific launches an ambitious new platform targeting the multi-billion dollar anime, manga, and creator markets. Can it beat the competition?

A lucrative deal for a rare disease voucher positions Fortress Biotech for profitability, highlighting a successful strategy and a breakthrough for Menkes patients.

BioNexus Gene Lab appoints Matthew Barsing to lead its Chemrex subsidiary, signaling a strategic overhaul from industrial chemicals to biotech and advanced tech.

Satellogic launches its Aleph Observer service, shifting the satellite industry from ad-hoc snapshots to persistent, large-scale global monitoring.

Recursion, HighRes, and NVIDIA are pioneering automated drug discovery. Inside the 'Physical AI' revolution poised to radically accelerate the hunt for new cures.

Most hospitals have static defenses ill-equipped for modern threats. A new, free framework offers a clinically-informed path to a dynamic Zero Trust posture.

With its stock under pressure, Geron will face investors to defend its RYTELO sales strategy and address delays in its pivotal myelofibrosis trial.

America's power grid is at a breaking point. A new report reveals how homeowners and smart tech are forging a resilient, decentralized energy future.

Amid financial headwinds, CISO Global appoints a new EVP to accelerate AI innovation, enhance operational efficiency, and gain a competitive edge.

Outdoor Holding Co. ends a major legal distraction with a $4.4M payment, allowing it to fully focus on innovating its GunBroker.com marketplace.

BioVie faces a pivotal moment, touting breakthrough drugs for Alzheimer's and cirrhosis while navigating clinical setbacks and financial pressures.

Humane Colorado and San Francisco SPCA partner with RKD Group, signaling a major shift to data-driven strategies to boost donations and save more lives.

At a key industry summit, Sutro Biopharma showcases its next-gen ADC platform, designed to overcome treatment resistance with "supercharged" dual-payload drugs.

As Lyell presents at three major investor conferences, the biotech's pipeline, financial health, and future in cancer therapy are under scrutiny.

A Malaysian biotech's new study shows its NK cell therapy is safe, using a novel, low-cost method that could make advanced cancer treatment affordable worldwide.

OptimumBank Holdings leverages its deep expertise in healthcare and multifamily real estate by launching OptimumFunding, a new HUD and FHA lending platform.

Facing financial headwinds, network supplier DAVOLINK is merging with LoadRunner, pivoting to the booming but brutal AI-driven industrial automation market.